| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO
1 company
Marshall Fordyce is President and CEO at VERA. From August 2022 to September 2026, the filings on record show 0 open-market purchases and 27 sales. Marshall Fordyce's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.2M at current prices.
Historically, Marshall Fordyce's trades have earned a strong insider score of 74/100 across 30 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +10.9%.
The VERA filings lean toward selling, a net 581,690 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 17,500 | $46.94 | $821,523.29 | -16.9% | -39.0% | -0.9% | |
| Nov 25, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 19,375 | $47.98 | $929,560.28 | -18.4% | -42.5% | -37.7% | |
| Nov 13, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 30,625 | $49.50 | $1,516,037.41 | -26.3% | -31.1% | -42.6% | |
| Oct 23, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 19,375 | $40.39 | $782,610.28 | -5.9% | -15.5% | -29.3% | |
| Oct 9, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 15,625 | $38.24 | $597,568.34 | -4.8% | +8.1% | -21.6% | |
| Sep 25, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 23,125 | $46.05 | $1,064,809.29 | -7.0% | -6.7% | -40.0% | |
| Sep 11, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 15,625 | $37.50 | $585,934.07 | -4.8% | +24.9% | -34.7% | |
| Aug 28, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 30,320 | $36.84 | $1,117,139.78 | -9.0% | +29.3% | -39.3% | |
| Aug 21, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sell | 14,471 | $39.76 | $575,424.84 | -4.3% | +14.9% | -43.4% | |
| Aug 14, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 15,625 | $37.56 | $586,926.56 | -4.4% | +28.1% | -43.9% |